(LEGN) Legend Biotech - Performance -22.4% in 12m
LEGN performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-11.07%
#39 in Peer-Group
Rel. Strength
21.96%
#6017 in Stock-Universe
Total Return 12m
-22.37%
#85 in Peer-Group
Total Return 5y
-8.99%
#37 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 1.00K |
| High / Low | USD |
|---|---|
| 52 Week High | 59.88 USD |
| 52 Week Low | 27.69 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 83.77 |
| Buy/Sell Signal +-5 | -0.95 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: LEGN (-22.4%) vs XBI (-6.2%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.94% | 73.2% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.16% | -5.32% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.99% | -0.49% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.6% | 32.8% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.29% | -6.6% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
17.1% | 57.4% | -4.19% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
-3.2% | 58.3% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
5.64% | 38.5% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: LEGN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for LEGN
| Total Return (including Dividends) | LEGN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 25.36% | 3.53% | 5.22% |
| 3 Months | 8.39% | 9.10% | 16.86% |
| 12 Months | -22.37% | -6.17% | 14.81% |
| 5 Years | -8.99% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | LEGN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 5.7% | 4.4% | 81% |
| 3 Months | 33.5% | 78.8% | 96.9% |
| 12 Months | -85.6% | -85.8% | 44.9% |
| 5 Years | 36.4% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th84.50 | 21.09% | 19.14% |
| 3 Month | %th55.00 | -0.64% | -7.25% |
| 12 Month | %th57.50 | -17.27% | -32.38% |
| 5 Years | %th81.00 | 20.08% | -57.04% |
FAQs
Does Legend Biotech (LEGN) outperform the market?
No,
over the last 12 months LEGN made -22.37%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.17%.
Over the last 3 months LEGN made 8.39%, while XBI made 9.10%.
Performance Comparison LEGN vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
LEGN vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 4.3% | 20.1% | -6.7% | -37% |
| US NASDAQ 100 | QQQ | 4.6% | 19.8% | -7.9% | -36% |
| German DAX 40 | DAX | 5.3% | 26% | -20.1% | -52% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 6% | 21.2% | -9.5% | -41% |
| Hongkong Hang Seng | HSI | 5.2% | 19% | -25.1% | -58% |
| India NIFTY 50 | INDA | 6.3% | 22% | -4.9% | -22% |
| Brasil Bovespa | EWZ | 2.3% | 17.1% | -33.4% | -34% |
LEGN vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 4.9% | 18.8% | -11.4% | -49% |
| Consumer Discretionary | XLY | 3.6% | 22.5% | 1.2% | -41% |
| Consumer Staples | XLP | 3.9% | 25.4% | -6.6% | -33% |
| Energy | XLE | 5% | 20.4% | -1.5% | -21% |
| Financial | XLF | 3.8% | 20.9% | -10.6% | -52% |
| Health Care | XLV | 5.5% | 23% | 1.3% | -19% |
| Industrial | XLI | 3.6% | 21.1% | -13.7% | -47% |
| Materials | XLB | 2.4% | 20.7% | -11.3% | -29% |
| Real Estate | XLRE | 4.4% | 24.1% | -4.3% | -36% |
| Technology | XLK | 4.1% | 16.5% | -9.8% | -34% |
| Utilities | XLU | 5.6% | 25.4% | -8.1% | -45% |
| Aerospace & Defense | XAR | 5.5% | 17.7% | -23.9% | -72% |
| Biotech | XBI | 4.6% | 21.8% | 7.4% | -16% |
| Homebuilder | XHB | 1.3% | 16.8% | 1.2% | -27% |
| Retail | XRT | 1.2% | 21.1% | -2.1% | -34% |
LEGN vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 4.3% | 17.8% | 3.11% | -15% |
| Natural Gas | UNG | 9.1% | 35.4% | 1.8% | -16% |
| Gold | GLD | 6.3% | 25.9% | -26.5% | -63% |
| Silver | SLV | 5.9% | 18.8% | -24.6% | -43% |
| Copper | CPER | 5.8% | 20.4% | -25.3% | -36% |
LEGN vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 7.2% | 22.7% | -2.2% | -21% |
| iShares High Yield Corp. Bond | HYG | 6% | 23.6% | -5.1% | -33% |